Stratasys is expanding the suite of 3D printers and materials for anatomical modeling that are validated by its collaborator Materialise as part of FDA-cleared Materialise Mimics inPrint software. Materialise Mimics inPrint is the first, and currently only, 3D printing software cleared by the FDA for use in creating anatomical models for patient care.
Model of patient’s left atrial appendage (LAA) created with Stratasys and Materialise technology is intended to allow surgeons to select the appropriate device and plan the optimal approach to occlude the LAA. Image provided by Materialise
PolyJet multi-material and multi-color materials that are validated suit the J750 and J735 3D Printers and the desktop Objet30 Prime 3D Printer.
Creating highly-accurate models using multiple textures that mimic human tissue, the Stratasys J750 3D Printer has eight different materials now validated with the Materialise FDA-cleared software.
The software enables physicians and hospitals to leverage 3D printing at point-of-care.
“Historically, pre-surgical planning relied on 2D imaging requiring physicians to mentally reconstruct the patient anatomy. But 3D printing evolves this approach by putting precise replicas of patient anatomy directly in physician hands. Our collaboration with Materialise is a huge step towards unlocking the potential of this technology for patient care,” says Eyal Miller, Head of Healthcare Business Unit, Stratasys. “Now the 3D printer that every hospital needs to power their medical modeling comes with additional options for an FDA-cleared software solution.”
In March of 2018, Materialise Mimics inPrint was cleared by the FDA, becoming the only solution with 510(k) clearance as an end-to-end 3D printing solution, as well as a fully comprehensive 3D printing solution for anatomical modeling. According to company reports, of the top 20 U.S. hospitals as ranked by U.S. News & World Report, 16 have implemented a medical 3D printing strategy using Materialise Mimics technology.
“By validating Stratasys’ 3D printing technologies through our certification process, we’re giving doctors and hospitals better access to high-quality anatomical models for personalized care to patients,” said Bryan Crutchfield, Vice President and General Manager of Materialise North America. “At Materialise, we take a hardware-agnostic approach to software development, offering the flexibility to partner with other leaders in the 3D printing industry like Stratasys – a company committed to addressing requirements of the medical community.”
The Stratasys J735/J750 3D Printers develop highly complex models using multiple textures, while combining hard and soft materials to mimic human tissue. The unique combination of transparency with multiple color re-creation ensures practitioners can differentiate anatomy, view critical structures within an organ replica, and create realistic representations of any bone, tissue, and organ.
The Stratasys’ Objet30 Prime 3D Printer desktop platform provides an entry point to hospitals seeking a point-of-care printing solution – without compromising quality, resolution or accuracy. The versatile offering supports a range of anatomical models and applications, including orthopedic, cardiac, neurosurgery and other use-cases for visualization, surgical planning, training and education.
Stratasys
www.stratasys.com/medical
Filed Under: 3D printing • additive • stereolithography